Medicine Price Hike: Major news for common people. A new challenge for everyday consumers is on the horizon. Starting April 1, 2026, the costs of paracetamol, antibiotics, and other vital medications are expected to rise. The government has sanctioned a 0.6% price hike for medicines included in the National List of Essential Medicines (NLEM). This adjustment will affect over 1,000 essential medications.
The National Pharmaceutical Pricing Authority (NPPA) stated, “According to the Wholesale Price Index (WPI) data from the Office of the Economic Adviser, Department for Industry and Internal Trade, Ministry of Commerce and Industry, the annual WPI change for 2025 compared to the same period in 2024 is (+) 0.64956%.” The revised prices will apply to more than 1,000 medicines on the NLEM.
Which significant medications will be impacted?
Price adjustments for controlled drugs can occur once a year. The essential drugs list features paracetamol, the antibiotic azithromycin for bacterial infections, medications for anemia, vitamins, and minerals. Additionally, some treatments for moderate to severe COVID-19 patients, along with steroids, are included in this list.
A pharmaceutical industry representative noted that this slight increase comes at a time when escalating input costs due to the Iran conflict have greatly affected the industry’s profit margins.
A 25% rise in paracetamol and a 30% rise in ciprofloxacin
The Economic Times reported that industry experts indicated the ongoing conflict has caused a substantial rise in the prices of several key active pharmaceutical ingredients (APIs) and solvents, and this increase is unlikely to offer any relief. For instance, API prices have surged by an average of 30-35% in recent weeks. Industry officials have noted that glycerin prices have jumped by 64%, while paracetamol has seen a 25% increase and ciprofloxacin a 30% increase. Furthermore, the costs of packaging materials like polyvinyl chloride and aluminum foil have also risen by 40%.
What did the pharma lobby say?
A representative of a pharma lobby group, speaking on condition of anonymity, said, “Glycerin, propylene glycol, and solvents used in every liquid medicine like syrups and drops have become expensive. The prices of intermediates have also increased significantly. Given this, we need a better increase than this and we will present our case to NPPA.”
